Back
Fulcrum Therapeutics Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
47
FULC
Fulcrum Therapeutics
Last Price:
3.32
Seasonality Move:
67.13%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing selling pressure, which indicates risk of future bearish movement.
Fulcrum Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.48 | Buy |
| 20-day SMA: | 3.38 | Buy |
| 50-day SMA: | 4.06 | Sell |
| 200-day SMA: | 7.33 | Sell |
| 8-day EMA: | 3.5 | Buy |
| 20-day EMA: | 3.5 | Buy |
| 50-day EMA: | 4.32 | Sell |
| 200-day EMA: | 6.19 | Sell |
Fulcrum Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 47.89 | Sell |
| Chaikin Money Flow: | -662910 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.24 - 3.56) | Buy |
| Bollinger Bands (100): | (3.61 - 8.65) | Sell |
Fulcrum Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fulcrum Therapeutics Stock
Is Fulcrum Therapeutics Stock a Buy?
- Fulcrum Therapeutics share price is 3.57 while FULC 8-day simple moving average is 3.48, which is a Buy signal.
- The stock price of FULC is 3.57 while Fulcrum Therapeutics 20-day SMA is 3.38, which makes it a Buy.
- Fulcrum Therapeutics 50-day simple moving average is 4.06 while FULC share price is 3.57, making it a Sell technically.
- FULC stock price is 3.57 and Fulcrum Therapeutics 200-day simple moving average is 7.33, creating a Sell signal.
FULC Technical Analysis vs Fundamental Analysis
Sell
47
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy or a Sell?
-
Fulcrum Therapeutics stock is rated a Sell
The current Fulcrum Therapeutics [FULC] share price is $3.57. The Score for FULC is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Fulcrum Therapeutics Stock Info
Market Cap:
222.77M
Price in USD:
3.57
Share Volume:
870.07K
Fulcrum Therapeutics 52-Week Range
52-Week High:
13.70
52-Week Low:
2.87
Sell
47
Fulcrum Therapeutics (FULC)
is a Sell
Fulcrum Therapeutics Share Price Forecast
-
What is the Fulcrum Therapeutics stock price today?
The Fulcrum Therapeutics stock price is 3.57 USD today. -
Will FULC stock go up or go down?
Fulcrum Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Fulcrum Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fulcrum Therapeutics is overvalued.
Is Fulcrum Therapeutics Stock a Buy?
- Fulcrum Therapeutics share price is 3.57 while FULC 8-day exponential moving average is 3.50, which is a Buy signal.
- The stock price of FULC is 3.57 while Fulcrum Therapeutics 20-day EMA is 3.50, which makes it a Buy.
- Fulcrum Therapeutics 50-day exponential moving average is 4.32 while FULC share price is 3.57, making it a Sell technically.
- FULC stock price is 3.57 and Fulcrum Therapeutics 200-day simple moving average is 6.19, creating a Sell signal.
Fundamental Analysis of Fulcrum Therapeutics
Is Fulcrum Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.42 per share, and a decrease next year of $0.79 per share.
Technical Analysis of Fulcrum Therapeutics
Should I short Fulcrum Therapeutics stock?
- FULC Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Fulcrum Therapeutics is a Sell
- Fulcrum Therapeutics Relative Strength Index (RSI) is 47.89, which suggest Fulcrum Therapeutics is oversold
- The Bollinger Bands (25) for Fulcrum Therapeutics is (3.24 - 3.56), which suggest Fulcrum Therapeutics is a Sell
- The Bollinger Bands (100) for Fulcrum Therapeutics is (3.61 - 8.65), which suggest Fulcrum Therapeutics is a Sell
* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.